======= C6orf136 ======= == Gene Information == * **Official Symbol**: C6orf136 * **Official Name**: chromosome 6 open reading frame 136 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=221545|221545]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5SQH8|Q5SQH8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C6orf136&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C6orf136|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |DUF2358| No GO term information is available for this gene. \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-3.89| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|-3.58| |[[:results:exp363|GSK-J4 1-1.25μM to day4 R07 exp363]]|-3.51| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|-2.67| |[[:results:exp183|IU1-C 25μM R04 exp183]]|-2.66| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|-2.65| |[[:results:exp292|Menadione 5μM R06 exp292]]|-2.61| |[[:results:exp274|Citral 50μM R06 exp274]]|-2.55| |[[:results:exp114|A-196 10μM R03 exp114]]|-2.21| |[[:results:exp358|FK-506 5μM R07 exp358]]|-2.11| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-2.11| |[[:results:exp519|RS-1 10μM R08 exp519]]|-2.09| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|-1.99| |[[:results:exp285|GW501516 25μM R06 exp285]]|-1.94| |[[:results:exp148|SB202190 10μM R03 exp148]]|-1.92| |[[:results:exp34|Rotenone 20μM R00 exp34]]|-1.91| |[[:results:exp224|CB-839 10μM R05 exp224]]|-1.9| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|-1.89| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-1.85| |[[:results:exp135|MS023 7μM R03 exp135]]|-1.84| |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|-1.83| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-1.82| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-1.82| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.8| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|-1.79| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|-1.76| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-1.71| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|1.7| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|1.76| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|1.85| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|1.94| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|1.98| |[[:results:exp11|CCCP 1μM R00 exp11]]|2.02| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|2.48| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.4| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15778 * **Expression level (log2 read counts)**: 3.77 {{:chemogenomics:nalm6 dist.png?nolink |}}